154 related articles for article (PubMed ID: 30862694)
21. PAK1 and PAK2 in cell metabolism regulation.
Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
[TBL] [Abstract][Full Text] [Related]
22. Depletion of p21-activated kinase 1 up-regulates the immune system of APC
Huynh N; Wang K; Yim M; Dumesny CJ; Sandrin MS; Baldwin GS; Nikfarjam M; He H
BMC Cancer; 2017 Jun; 17(1):431. PubMed ID: 28629331
[TBL] [Abstract][Full Text] [Related]
23. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
Hasegawa H; Yamada Y; Tsukasaki K; Mori N; Tsuruda K; Sasaki D; Usui T; Osaka A; Atogami S; Ishikawa C; Machijima Y; Sawada S; Hayashi T; Miyazaki Y; Kamihira S
Leukemia; 2011 Apr; 25(4):575-87. PubMed ID: 21242994
[TBL] [Abstract][Full Text] [Related]
24. Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells.
Raja R; Sahasrabuddhe NA; Radhakrishnan A; Syed N; Solanki HS; Puttamallesh VN; Balaji SA; Nanjappa V; Datta KK; Babu N; Renuse S; Patil AH; Izumchenko E; Prasad TS; Chang X; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
Oncotarget; 2016 Sep; 7(38):61229-61245. PubMed ID: 27542207
[TBL] [Abstract][Full Text] [Related]
25. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
26. p21-activated kinase inhibitors.
Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
[TBL] [Abstract][Full Text] [Related]
27. Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.
Ma Y; McCarty SK; Kapuriya NP; Brendel VJ; Wang C; Zhang X; Jarjoura D; Saji M; Chen CS; Ringel MD
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1314-22. PubMed ID: 23709653
[TBL] [Abstract][Full Text] [Related]
28. p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway.
Radu M; Lyle K; Hoeflich KP; Villamar-Cruz O; Koeppen H; Chernoff J
Mol Cell Biol; 2015 Dec; 35(23):3990-4005. PubMed ID: 26391956
[TBL] [Abstract][Full Text] [Related]
29. Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells.
Kuželová K; Grebeňová D; Holoubek A; Röselová P; Obr A
PLoS One; 2014; 9(3):e92560. PubMed ID: 24664099
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling.
Sementino E; Kadariya Y; Cheung M; Menges CW; Tan Y; Kukuyan AM; Shrestha U; Karchugina S; Cai KQ; Peri S; Duncan JS; Chernoff J; Testa JR
Mol Cancer Res; 2022 May; 20(5):699-711. PubMed ID: 35082167
[TBL] [Abstract][Full Text] [Related]
31. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.
Ishii T; Ishida T; Utsunomiya A; Inagaki A; Yano H; Komatsu H; Iida S; Imada K; Uchiyama T; Akinaga S; Shitara K; Ueda R
Clin Cancer Res; 2010 Mar; 16(5):1520-31. PubMed ID: 20160057
[TBL] [Abstract][Full Text] [Related]
32. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.
Murray BW; Guo C; Piraino J; Westwick JK; Zhang C; Lamerdin J; Dagostino E; Knighton D; Loi CM; Zager M; Kraynov E; Popoff I; Christensen JG; Martinez R; Kephart SE; Marakovits J; Karlicek S; Bergqvist S; Smeal T
Proc Natl Acad Sci U S A; 2010 May; 107(20):9446-51. PubMed ID: 20439741
[TBL] [Abstract][Full Text] [Related]
33. p21-activated kinase 1 activity is required for histone H3 Ser
Zhang N; Li X; Liu X; Cao Y; Chen D; Liu X; Wang Q; Du J; Weng J; Ma W
Reprod Fertil Dev; 2017 Jul; 29(7):1287-1296. PubMed ID: 27166635
[TBL] [Abstract][Full Text] [Related]
34. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
[TBL] [Abstract][Full Text] [Related]
36. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.
Ishitsuka K; Kunami N; Katsuya H; Nogami R; Ishikawa C; Yotsumoto F; Tanji H; Mori N; Takeshita M; Miyamoto S; Tamura K
Cancer Lett; 2012 Apr; 317(2):218-25. PubMed ID: 22138435
[TBL] [Abstract][Full Text] [Related]
37. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.
Coniglio SJ; Zavarella S; Symons MH
Mol Cell Biol; 2008 Jun; 28(12):4162-72. PubMed ID: 18411304
[TBL] [Abstract][Full Text] [Related]
38. Discovery of pyrroloaminopyrazoles as novel PAK inhibitors.
Guo C; McAlpine I; Zhang J; Knighton DD; Kephart S; Johnson MC; Li H; Bouzida D; Yang A; Dong L; Marakovits J; Tikhe J; Richardson P; Guo LC; Kania R; Edwards MP; Kraynov E; Christensen J; Piraino J; Lee J; Dagostino E; Del-Carmen C; Deng YL; Smeal T; Murray BW
J Med Chem; 2012 May; 55(10):4728-39. PubMed ID: 22554206
[TBL] [Abstract][Full Text] [Related]
39. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
Onimaru Y; Tsukasaki K; Murata K; Imaizumi Y; Choi YL; Hasegawa H; Sugahara K; Yamada Y; Hayashi T; Nakashima M; Taguchi T; Mano H; Kamihira S; Tomonaga M
Int J Oncol; 2008 Oct; 33(4):697-703. PubMed ID: 18813782
[TBL] [Abstract][Full Text] [Related]
40. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.
Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS
Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
